40 Result(s)
-
Article
Image quality of whole-body diffusion MR images comparing deep-learning accelerated and conventional sequences
To compare the image quality of deep learning accelerated whole-body (WB) with conventional diffusion sequences.
-
Article
Evaluating prostate cancer bone metastases response with whole-body MRI: What we know and still need to know
-
Article
Open AccessPI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI
Multiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and function...
-
Article
Open AccessESR Essentials: using the right scoring system in prostate MRI—practice recommendations by ESUR
MRI has gained prominence in the diagnostic workup of prostate cancer (PCa) patients, with the Prostate Imaging Reporting and Data System (PI-RADS) being widely used for cancer detection. Beyond PI-RADS, other...
-
Article
Open AccessReduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies
To develop and test zone-specific prostate-specific antigen density (sPSAD) combined with PI-RADS to guide prostate biopsy decision strategies (BDS).
-
Article
Key learning on the promise and limitations of MRI in prostate cancer screening
MRI retains its ability to reduce the harm of prostate biopsies by decreasing biopsy rates and the detection of indolent cancers in population-based screening studies aiming to find clinically significant pros...
-
Article
Prostate cancer screening—step** forward with MRI
To comprehensively review the literature on the integration of MRI as a diagnostic tool in prostate cancer screening and offer practical recommendations for optimising its use.
-
Article
Are upgraded DCE-positive PI-RADS 3 lesions truly suspicious for clinically significant prostate cancer?
-
Article
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway
Multiparametric MRI of the prostate is now recommended as the initial diagnostic test for men presenting with suspected prostate cancer, with a negative MRI enabling safe avoidance of biopsy and a positive res...
-
Article
Towards a judicious use of perilesional biopsy in the era of MRI-targeting, parting of the ways from systematic prostate biopsy
-
Article
Balancing the benefits and harms of MRI-directed biopsy pathways
• Before a prostate biopsy, the likely benefits and the harms emanating from true and false test MRI results need to be balanced. Prioritizing patients’ preferences and their tolerance to potenti...
-
Article
Assessing the clinical performance of artificial intelligence software for prostate cancer detection on MRI
-
Article
Open AccessESUR/ESUI position paper: develo** artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging
Artificial intelligence developments are essential to the successful deployment of community-wide, MRI-driven prostate cancer diagnosis. AI systems should ensure that the main benefits of biopsy avoidance are ...
-
Article
Open AccessWhole-body magnetic resonance imaging (WB-MRI) for cancer screening: recommendations for use
Whole-body magnetic resonance imaging (WB-MRI) is currently recommended for cancer screening in adult and paediatric subjects with cancer predisposition syndromes, representing a substantial aid for prolonging...
-
Article
Correction to: Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer
A Correction to this paper has been published: https://doi.org/10.1007/s00330-021-07795-z
-
Article
Open AccessIntroducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer
“Node-RADS” addresses the lack of consensus in the radiologic assessment of lymph node involvement by cancer and meets the increasing demand for structured reporting on the likelihood of disease involvement. N...
-
Article
A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis
• Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis.
-
Article
Open AccessDelivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosis
Pre-biopsy multiparametric MRI is now recommended by multiple guidelines, not only for men with persistent suspicion of prostate cancer after prior negative systematic biopsy, but also at initial screening bef...
-
Article
Bone metastases
Bone is the most frequent site for metastasis for many cancers, notably for tumours originating in the breast and the prostate. Tumour cells can escape from the primary tumour site and colonize the bone microe...
-
Article
Rethinking prostate cancer screening: could MRI be an alternative screening test?
In the past decade rigorous debate has taken place about population-based screening for prostate cancer. Although screening by serum PSA levels can reduce prostate cancer-specific mortality, it is unclear whet...
